Hugh M. Davis

Insider Reports History

Location
Wayne, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hugh M. Davis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. President and COO, Director Restricted Stock Units 80.3K $185K $2.48 Dec 2, 2025 Direct
Aclaris Therapeutics, Inc. President and COO, Director Common Stock 26.8K $60.7K $2.27 Dec 2, 2025 Direct
Aclaris Therapeutics, Inc. President and COO, Director Employee Stock Option (Right to Buy) 262K Feb 3, 2025 Direct

Insider Reports Filed by Hugh M. Davis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Dec 2, 2025 2 $0 4 Dec 4, 2025 President and COO, Director
ACRS Aclaris Therapeutics, Inc. Feb 3, 2025 2 $0 4 Feb 4, 2025 President and COO, Director
ACRS Aclaris Therapeutics, Inc. Dec 2, 2024 2 $0 4 Dec 3, 2024 President and COO, Director
ACRS Aclaris Therapeutics, Inc. Nov 18, 2024 0 $0 3 Nov 18, 2024 President and COO, Director